This method shows selective alkynylation of C(sp3)–H in amides, highlighting the role of CpERh(III) and 2-pyridone ligand.
A novel catalytic strategy that harnesses native amides as directing groups for the site-selective alkynylation of C(sp3)–H sites was discovered. This protocol relies on the use of an electron-deficient CpERh(III) complex and 2-pyridone ligand to facilitate formation of new C(sp3)–C(sp) bonds at both primary and secondary beta-C(sp3)–H sites. Exceptional reactivity was observed for the distal C(sp3)–alkynylation of cyclopropane carboxamides, affording a series of unique alkynylated cyclopropane scaffolds amenable to further derivatization at both the amide and alkyne functionality. The utility of this novel catalytic strategy was further exemplified through the functionalization of pharmaceutical derivatives and rapid synthesis of drug-biotin and drug-fluorescent probe conjugates.
No takes yet. Share an insight, caveat, or question.
Tong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: